GRI BIO INC (GRI:NASDAQ)
$2.29 -0.16 (-6.5306%)
Analysed GRI BIO INC (GRI:NASDAQ) News Sources
GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions
08-04-2026
yahoo.com
How The Grainger (LSE:GRI) Investment Story Is Evolving As The Narrative Holds Steady
04-04-2026
yahoo.com
3 Undervalued Small Caps In Global With Recent Insider Activity
02-04-2026
yahoo.com
GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment
17-02-2026
yahoo.com
JTC Team Companies to Present in Webull Corporate Connect Webinar Series Happening February 10-11, 2026
09-02-2026
yahoo.com
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
05-02-2026
yahoo.com
GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights
04-02-2026
yahoo.com
GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF
28-01-2026
yahoo.com
GRI Bio Secures New U.S. Composition of Matter Patent Covering Novel Compound Structures
26-01-2026
yahoo.com
GRI Bio Announces Reverse Stock Split
21-01-2026
yahoo.com
What is the current price of GRI BIO INC (GRI:NASDAQ)?
The current price of GRI BIO INC (GRI:NASDAQ) is $2.29.
GRI BIO INC (GRI:NASDAQ) absolute price change since previous trading day?
The absolute price change of GRI BIO INC (GRI:NASDAQ) since the previous trading day is $-0.16.
GRI BIO INC (GRI:NASDAQ) percentage price change since previous trading day?
The percentage price change of GRI BIO INC (GRI:NASDAQ) since the previous trading day is -6.5306%.
What is the most recent average sentiment score for GRI BIO INC (GRI:NASDAQ)?
The most recent average sentiment score for GRI BIO INC (GRI:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for GRI BIO INC (GRI:NASDAQ)?
The most recent sentiment for GRI BIO INC (GRI:NASDAQ) is .
SEC-8K** Filing Available For GRI BIO INC (GRI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.